(Q38988213)

8 September 2017

title

Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo (English)

1 reference

8 September 2017

1 reference

1 reference

1 reference

Jinxia He

1

1 reference

8 September 2017

Ganfeng Xie

2

1 reference

8 September 2017

Jingtao Tong

3

1 reference

8 September 2017

Yonghai Peng

4

1 reference

8 September 2017

Haihui Huang

5

1 reference

8 September 2017

Jianjun Li

6

1 reference

8 September 2017

Ning Wang

7

1 reference

8 September 2017

Houjie Liang

8

1 reference

8 September 2017

publication date

1 November 2014

1 reference

Cell Biochemistry and Biophysics

8 September 2017

published in

1 reference

8 September 2017

volume

70

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

1343-1350

1 reference

5-Fluorouracil: mechanisms of action and clinical strategies

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

5-Fluorouracil: mechanisms of resistance and reversal strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Dual roles of PKM2 in cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

The role of microRNAs in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Rethinking the Warburg effect with Myc micromanaging glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Targeting cellular metabolism to improve cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Targeting cancer metabolism: a therapeutic window opens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Diversifying microRNA sequence and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0062-X

10.1007/S12013-014-0062-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1028000364

0 references

1 reference